By PPN News Staff
The FDA approved insulin human in 0.9% sodium chloride injection (Myxredlin, Baxter), the first ready-to-use insulin for IV infusion in the hospital and other acute care settings.
The insulin for IV infusion is indicated for use as a short-acting human insulin to improve glycemic control in adults and children with diabetes mellitus. It is intended for use only in acute care settings under medical supervision.